UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8556

2024

Volltextzugriff (PDF)

Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients

Cancers, 2021-12, Vol.13 (23), p.6073

2021

Volltextzugriff (PDF)

Strong Hydrogen Bonds in Acetylenedicarboxylic Acid Dihydrate

International journal of molecular sciences, 2022-05, Vol.23 (11), p.6164

2022

Volltextzugriff (PDF)

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

Proceedings of the National Academy of Sciences - PNAS, 2009-07, Vol.106 (27), p.11294-11299

2009

Volltextzugriff (PDF)

Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy

Cancers, 2022-07, Vol.14 (14), p.3527

2022

Volltextzugriff (PDF)

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

Scientific reports, 2023-03, Vol.13 (1), p.3705-3705, Article 3705

2023

Volltextzugriff (PDF)

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

Haematologica (Roma), 2021-07, Vol.106 (7), p.1923-1931

2021

Volltextzugriff (PDF)

Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment

Mediterranean journal of hematology and infectious diseases, 2023, Vol.15 (1), p.e2023025-e2023025

2023

Volltextzugriff (PDF)

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma

Cancers, 2023-03, Vol.15 (7), p.2091

2023

Volltextzugriff (PDF)

Characteristics and survival of patients with cancer with intended off-label use—a cohort study

BMJ open, 2022-05, Vol.12 (5), p.e060453-e060453

2022

Volltextzugriff (PDF)

Small Cellular Particles from European Spruce Needle Homogenate

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4349

2023

Volltextzugriff (PDF)

Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia

Haematologica (Roma), 2020-01, Vol.105 (1), p.e9-e12

2020

Volltextzugriff (PDF)

Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party

Frontiers in immunology, 2023-09, Vol.14, p.1252811-1252811

2023

Volltextzugriff (PDF)

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma

Turkish journal of haematology, 2023-08, Vol.40 (3), p.187-196

2023

Volltextzugriff (PDF)

BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study

Journal of clinical medicine, 2022-06, Vol.11 (13), p.3748

2022

Volltextzugriff (PDF)

TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells

Haematologica (Roma), 2019-04, Vol.104 (4), p.766-777

2019

Volltextzugriff (PDF)

CAR‐T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement

HemaSphere, 2023-12, Vol.7 (12), p.e984-n/a

2023

Volltextzugriff (PDF)

Diagnosis and treatment of follicular lymphoma: an update

Swiss medical weekly, 2018-01, Vol.148, p.w14635

2018

Volltextzugriff (PDF)

Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology

Current oncology (Toronto), 2022-01, Vol.29 (2), p.766-776

2022

Volltextzugriff (PDF)

Amyloid Formation of Stefin B Protein Studied by Infrared Spectroscopy

Frontiers in bioscience (Landmark. Print), 2023-03, Vol.28 (3), p.46-46

2023

Volltextzugriff (PDF)

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

Cells (Basel, Switzerland), 2022-09, Vol.11 (17), p.2747

2022

Volltextzugriff (PDF)

"Toys for boys?"

Swiss medical forum, 2017-01, Vol.17 (5)

Novak, Urban

2017

Volltextzugriff (PDF)

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

Journal for immunotherapy of cancer, 2023-04, Vol.11 (4), p.e006406

2023

Volltextzugriff (PDF)

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

BMC cancer, 2017-04, Vol.17 (1), p.265-265, Article 265

2017

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications

Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients

Strong Hydrogen Bonds in Acetylenedicarboxylic Acid Dihydrate

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma

Characteristics and survival of patients with cancer with intended off-label use—a cohort study

Small Cellular Particles from European Spruce Needle Homogenate

Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia

Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma

BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study

TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells

CAR‐T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement

Diagnosis and treatment of follicular lymphoma: an update

Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology

Amyloid Formation of Stefin B Protein Studied by Infrared Spectroscopy

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

"Toys for boys?"

Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Suchergebnisse filtern